Barriers to Initiating Insulin in Type 2 Diabetes Patients

Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities

Meryl Brod, Suzanne Lessard Alolga, Luigi Meneghini

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then used to develop a clinically relevant, cross-culturally valid patient education tool with the goal of providing unbiased, medically informative statements addressing these barriers.

Methods: Thirteen focus groups were conducted in five countries (Germany, Sweden, The Netherlands, UK, and USA) to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months (n = 87). Additionally, a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patients.

Results: On the basis of the interview data, the ten questions that asked about the most important barriers were generated. The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns, and the educational tool “Questions about Starting Insulin: Information on the Myths, Misconceptions and Clinical Realities about Insulin” was drafted. The draft tool was pilot tested in a group of patients and finalized.

Conclusions: Patient misconceptions, as well as some clinical realities, about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management. The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician, and facilitate patient–health-care provider interactions.

Original languageEnglish (US)
Pages (from-to)437-450
Number of pages14
JournalPatient
Volume7
Issue number4
DOIs
StatePublished - Nov 22 2014

Fingerprint

Patient Education
Type 2 Diabetes Mellitus
Insulin
Physicians
Therapeutics
Disease Management
Focus Groups
Sweden
Netherlands
Germany
Interviews

ASJC Scopus subject areas

  • Nursing (miscellaneous)
  • Medicine(all)

Cite this

Barriers to Initiating Insulin in Type 2 Diabetes Patients : Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities. / Brod, Meryl; Alolga, Suzanne Lessard; Meneghini, Luigi.

In: Patient, Vol. 7, No. 4, 22.11.2014, p. 437-450.

Research output: Contribution to journalArticle

@article{f393b8c50d0c437eab80853da898809c,
title = "Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities",
abstract = "Purpose: The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then used to develop a clinically relevant, cross-culturally valid patient education tool with the goal of providing unbiased, medically informative statements addressing these barriers.Methods: Thirteen focus groups were conducted in five countries (Germany, Sweden, The Netherlands, UK, and USA) to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months (n = 87). Additionally, a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patients.Results: On the basis of the interview data, the ten questions that asked about the most important barriers were generated. The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns, and the educational tool “Questions about Starting Insulin: Information on the Myths, Misconceptions and Clinical Realities about Insulin” was drafted. The draft tool was pilot tested in a group of patients and finalized.Conclusions: Patient misconceptions, as well as some clinical realities, about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management. The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician, and facilitate patient–health-care provider interactions.",
author = "Meryl Brod and Alolga, {Suzanne Lessard} and Luigi Meneghini",
year = "2014",
month = "11",
day = "22",
doi = "10.1007/s40271-014-0068-x",
language = "English (US)",
volume = "7",
pages = "437--450",
journal = "Patient",
issn = "1178-1653",
publisher = "Springer Science + Business Media",
number = "4",

}

TY - JOUR

T1 - Barriers to Initiating Insulin in Type 2 Diabetes Patients

T2 - Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities

AU - Brod, Meryl

AU - Alolga, Suzanne Lessard

AU - Meneghini, Luigi

PY - 2014/11/22

Y1 - 2014/11/22

N2 - Purpose: The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then used to develop a clinically relevant, cross-culturally valid patient education tool with the goal of providing unbiased, medically informative statements addressing these barriers.Methods: Thirteen focus groups were conducted in five countries (Germany, Sweden, The Netherlands, UK, and USA) to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months (n = 87). Additionally, a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patients.Results: On the basis of the interview data, the ten questions that asked about the most important barriers were generated. The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns, and the educational tool “Questions about Starting Insulin: Information on the Myths, Misconceptions and Clinical Realities about Insulin” was drafted. The draft tool was pilot tested in a group of patients and finalized.Conclusions: Patient misconceptions, as well as some clinical realities, about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management. The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician, and facilitate patient–health-care provider interactions.

AB - Purpose: The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then used to develop a clinically relevant, cross-culturally valid patient education tool with the goal of providing unbiased, medically informative statements addressing these barriers.Methods: Thirteen focus groups were conducted in five countries (Germany, Sweden, The Netherlands, UK, and USA) to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months (n = 87). Additionally, a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patients.Results: On the basis of the interview data, the ten questions that asked about the most important barriers were generated. The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns, and the educational tool “Questions about Starting Insulin: Information on the Myths, Misconceptions and Clinical Realities about Insulin” was drafted. The draft tool was pilot tested in a group of patients and finalized.Conclusions: Patient misconceptions, as well as some clinical realities, about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management. The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician, and facilitate patient–health-care provider interactions.

UR - http://www.scopus.com/inward/record.url?scp=84911984812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911984812&partnerID=8YFLogxK

U2 - 10.1007/s40271-014-0068-x

DO - 10.1007/s40271-014-0068-x

M3 - Article

VL - 7

SP - 437

EP - 450

JO - Patient

JF - Patient

SN - 1178-1653

IS - 4

ER -